Why You Should Thank Contract Research Organizations

The contract research organization (CRO) industry is expected to grow from $22.9 billion in 2016 to $32.7 billion by 2025, according to a report by Grand View Research. This growth is attributed to the rising demand for outsourced clinical research services, as well as the increasing number of drug approvals by the FDA.
There are many reasons why you should thank CROs for their services. Here are three of the most important reasons:
1. CROs Help Reduce Drug Development Costs
The cost of bringing a new drug to market can be astronomical. According to a report by the Tufts Center for the Study of Drug Development, the average cost of developing and gaining market approval for a new drug is $2.6 billion.
CROs can help reduce the cost of drug development by providing various services, such as clinical trial management, data management, and biostatistics. By outsourcing these services to CROs, pharmaceutical and biotechnology companies can save millions of dollars.
2. CROs Help Accelerate Drug Development
The time it takes to develop a new drug can also be prohibitively long. According to the Tufts report, it takes an average of 10 years to bring a new drug to market.
CROs can help accelerate drug development by providing various services, such as clinical trial management, data management, and biostatistics. By outsourcing these services to CROs, pharmaceutical and biotechnology companies can save years of development time.
3. CROs Help Improve Drug Development Success Rates
The success rate of bringing a new drug to market is extremely low. According to the Tufts report, the success rate of clinical trials is less than 10%.
CROs can help improve drug development success rates by providing various services, such as clinical trial management, data management, and biostatistics. By outsourcing these services to CROs, pharmaceutical and biotechnology companies can increase the chances of success for their clinical trials.
Thank you, CROs, for all that you do to help reduce the cost, time, and risk of drug development. We appreciate your efforts Contract Research Organization!
2. 3 Reasons to Stop Thinking About Contract Research Organizations
1. Contract Research Organizations (CROs) can be expensive.
2. CROs often have a bad reputation for being unresponsive to client needs.
3. CROs can be inflexible and slow to adapt to changing market conditions.
3. The Benefits of Working with a Contract Research Organization
There are many benefits to working with a contract research organization (CRO). Here are three of the most important benefits:
1. Increased Efficiency
CROs are experts in their field and are able to provide a higher level of efficiency than most in-house research teams. This is due to the fact that CROs have the staff and resources necessary to complete projects in a timely manner. In addition, CROs are often able to provide a higher level of quality control than in-house research teams.
2. Cost-Effective
Working with a CRO is often more cost-effective than conducting research in-house. This is due to the fact that CROs have economies of scale and can therefore pass on savings to their clients. In addition, CROs often have access to specialized equipment and resources that would be cost-prohibitive for most in-house research teams.
3. Increased Flexibility
CROs offer a high degree of flexibility when it comes to project scope and timelines. This is due to the fact that CROs are not bound by the same constraints as in-house research teams. This flexibility can be a major advantage when it comes to conducting complex or multi-phase research projects.
Comments
Post a Comment